WO2000010605A3 - Preventives or remedies for eye circulatory failure - Google Patents
Preventives or remedies for eye circulatory failure Download PDFInfo
- Publication number
- WO2000010605A3 WO2000010605A3 PCT/JP1999/004395 JP9904395W WO0010605A3 WO 2000010605 A3 WO2000010605 A3 WO 2000010605A3 JP 9904395 W JP9904395 W JP 9904395W WO 0010605 A3 WO0010605 A3 WO 0010605A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- eye
- circulatory failure
- preventives
- remedies
- side effect
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002341195A CA2341195A1 (en) | 1998-08-20 | 1999-08-12 | Prophylactic or therapeutic composition for ocular circulation disorders |
EP99937066A EP1112749A4 (en) | 1998-08-20 | 1999-08-12 | PROPHYLAXIS OR REMEDIES FOR CIRCULATORY EYE DISTURBANCE |
KR1020017002186A KR20010074838A (ko) | 1998-08-20 | 1999-08-12 | 안 순환 장해의 예방 또는 치료제 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP25193198 | 1998-08-20 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09762401 A-371-Of-International | 2001-02-07 | ||
US10/603,598 Division US20040086537A1 (en) | 1998-08-20 | 2003-06-26 | Prophylactic or threapeutic composition for ocular circulation disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000010605A2 WO2000010605A2 (fr) | 2000-03-02 |
WO2000010605A3 true WO2000010605A3 (en) | 2000-06-02 |
Family
ID=17230110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1999/004395 WO2000010605A2 (fr) | 1998-08-20 | 1999-08-12 | Prophylaxie ou remedes pour la perturbation circulatoire de l'oeil |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1112749A4 (ja) |
KR (1) | KR20010074838A (ja) |
CA (1) | CA2341195A1 (ja) |
WO (1) | WO2000010605A2 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU7954900A (en) * | 1999-10-25 | 2001-05-08 | Senju Pharmaceutical Co., Ltd. | Tension-relieving agents for ciliary muscle |
WO2003007964A1 (fr) * | 2001-07-18 | 2003-01-30 | Nippon Kayaku Kabushiki Kaisha | Remede ou agent preventif de cardiopathie ou d'anevrysme contenant un compose d'inhibition de la chymase |
KR20060120601A (ko) * | 2003-08-22 | 2006-11-27 | 데이진 화-마 가부시키가이샤 | 키마제 저해제를 유효 성분으로서 함유하는 약제 |
WO2008023784A1 (en) * | 2006-08-25 | 2008-02-28 | Showa University | Agent for amelioration of ophthalmic circulatory disorder |
Citations (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992010183A1 (en) * | 1990-12-14 | 1992-06-25 | Smithkline Beecham Plc | Use of angiotensin ii receptor antagonists in the treatment of diabetic retinopathy |
WO1992010179A1 (en) * | 1990-12-14 | 1992-06-25 | Smithkline Beecham Plc | Use of angiotensin ii receptor antagonists in the treatment of macular degeneration |
WO1993015732A1 (en) * | 1992-02-17 | 1993-08-19 | Ciba Vision Ag, Hettlingen | Treatment of glaucoma |
WO1993025574A1 (en) * | 1992-06-12 | 1993-12-23 | Pfizer Inc. | Inhibitors of angiotensin i chymase(s) including human heart chymase |
US5306824A (en) * | 1992-04-15 | 1994-04-26 | Georgia Tech Research Corporation | Biotinylated isocoumarins |
US5314815A (en) * | 1992-03-04 | 1994-05-24 | The Catholic University Of America | Method for temporarily inhibiting or deactivating serine hydrolase and adduct of serine hydrolase with a phosphonate or phosphate compound |
WO1996004248A1 (fr) * | 1994-07-29 | 1996-02-15 | Suntory Limited | Derives d'imidazolidine et son utilisation |
JPH0867674A (ja) * | 1993-07-02 | 1996-03-12 | Senju Pharmaceut Co Ltd | 眼圧降下剤 |
EP0713876A1 (en) * | 1994-11-24 | 1996-05-29 | Wakamoto Pharmaceutical Co., Ltd. | Triazine derivative, chymase activity inhibitor and nitric oxide production inhibitor |
WO1996033974A1 (fr) * | 1995-04-27 | 1996-10-31 | The Green Cross Corporation | Composes heterocycliques amides et leur utilisation medicinale |
JPH0931061A (ja) * | 1995-07-24 | 1997-02-04 | Suntory Ltd | ヒダントイン誘導体およびその用途 |
WO1997011941A1 (en) * | 1995-09-28 | 1997-04-03 | Suntory Limited | Quinazoline derivatives and use thereof |
JPH09124691A (ja) * | 1995-08-25 | 1997-05-13 | Green Cross Corp:The | ペプチド化合物およびそれを含有する医薬組成物 |
JPH107661A (ja) * | 1996-06-20 | 1998-01-13 | Green Cross Corp:The | 新規複素環式アミド化合物およびその医薬用途 |
JPH1053579A (ja) * | 1996-06-24 | 1998-02-24 | Fujisawa Pharmaceut Co Ltd | 新規アセトアミド化合物 |
WO1998009949A1 (fr) * | 1996-09-06 | 1998-03-12 | Nippon Kayaku Kabushiki Kaisha | Nouveaux derives d'acetamide et inhibiteurs de protease |
JPH1087567A (ja) * | 1996-06-05 | 1998-04-07 | Takeda Chem Ind Ltd | フェノールエステル誘導体、その製造法及び用途 |
WO1998018794A1 (fr) * | 1996-10-25 | 1998-05-07 | Yoshitomi Pharmaceutical Industries, Ltd. | Nouveaux composes d'amide heterocycliques et leur utilisation a des fins medicinales |
-
1999
- 1999-08-12 CA CA002341195A patent/CA2341195A1/en not_active Abandoned
- 1999-08-12 KR KR1020017002186A patent/KR20010074838A/ko not_active Application Discontinuation
- 1999-08-12 WO PCT/JP1999/004395 patent/WO2000010605A2/ja not_active Application Discontinuation
- 1999-08-12 EP EP99937066A patent/EP1112749A4/en not_active Withdrawn
Patent Citations (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992010183A1 (en) * | 1990-12-14 | 1992-06-25 | Smithkline Beecham Plc | Use of angiotensin ii receptor antagonists in the treatment of diabetic retinopathy |
WO1992010179A1 (en) * | 1990-12-14 | 1992-06-25 | Smithkline Beecham Plc | Use of angiotensin ii receptor antagonists in the treatment of macular degeneration |
WO1993015732A1 (en) * | 1992-02-17 | 1993-08-19 | Ciba Vision Ag, Hettlingen | Treatment of glaucoma |
US5314815A (en) * | 1992-03-04 | 1994-05-24 | The Catholic University Of America | Method for temporarily inhibiting or deactivating serine hydrolase and adduct of serine hydrolase with a phosphonate or phosphate compound |
US5306824A (en) * | 1992-04-15 | 1994-04-26 | Georgia Tech Research Corporation | Biotinylated isocoumarins |
WO1993025574A1 (en) * | 1992-06-12 | 1993-12-23 | Pfizer Inc. | Inhibitors of angiotensin i chymase(s) including human heart chymase |
JPH0867674A (ja) * | 1993-07-02 | 1996-03-12 | Senju Pharmaceut Co Ltd | 眼圧降下剤 |
WO1996004248A1 (fr) * | 1994-07-29 | 1996-02-15 | Suntory Limited | Derives d'imidazolidine et son utilisation |
EP0713876A1 (en) * | 1994-11-24 | 1996-05-29 | Wakamoto Pharmaceutical Co., Ltd. | Triazine derivative, chymase activity inhibitor and nitric oxide production inhibitor |
WO1996033974A1 (fr) * | 1995-04-27 | 1996-10-31 | The Green Cross Corporation | Composes heterocycliques amides et leur utilisation medicinale |
JPH0931061A (ja) * | 1995-07-24 | 1997-02-04 | Suntory Ltd | ヒダントイン誘導体およびその用途 |
JPH09124691A (ja) * | 1995-08-25 | 1997-05-13 | Green Cross Corp:The | ペプチド化合物およびそれを含有する医薬組成物 |
WO1997011941A1 (en) * | 1995-09-28 | 1997-04-03 | Suntory Limited | Quinazoline derivatives and use thereof |
JPH1087567A (ja) * | 1996-06-05 | 1998-04-07 | Takeda Chem Ind Ltd | フェノールエステル誘導体、その製造法及び用途 |
JPH107661A (ja) * | 1996-06-20 | 1998-01-13 | Green Cross Corp:The | 新規複素環式アミド化合物およびその医薬用途 |
JPH1053579A (ja) * | 1996-06-24 | 1998-02-24 | Fujisawa Pharmaceut Co Ltd | 新規アセトアミド化合物 |
WO1998009949A1 (fr) * | 1996-09-06 | 1998-03-12 | Nippon Kayaku Kabushiki Kaisha | Nouveaux derives d'acetamide et inhibiteurs de protease |
WO1998018794A1 (fr) * | 1996-10-25 | 1998-05-07 | Yoshitomi Pharmaceutical Industries, Ltd. | Nouveaux composes d'amide heterocycliques et leur utilisation a des fins medicinales |
Non-Patent Citations (1)
Title |
---|
See also references of EP1112749A4 * |
Also Published As
Publication number | Publication date |
---|---|
CA2341195A1 (en) | 2000-03-02 |
KR20010074838A (ko) | 2001-08-09 |
WO2000010605A2 (fr) | 2000-03-02 |
EP1112749A2 (en) | 2001-07-04 |
EP1112749A4 (en) | 2004-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0879601A3 (en) | Ophthalmic drug delivery system | |
EP0795548A4 (en) | CHINAZOZINE DERIVATIVES AND THEIR USE | |
IL124977A0 (en) | Oral administration of effective amounts of forms of hyaluronic acid | |
BR0013704A (pt) | Uso de inibidores do sistema renina-angiotensina na prevenção de casos cardiovasculares | |
WO2001015676A3 (en) | Compositions and methods for modulating hdl cholesterol and triglyceride levels | |
EP0895781A3 (en) | Use of benzofurans, benzothiophenes or indoles for the manufacture of a medicament for the treatment of conditions associated with an excess of tachykinins | |
WO2004105702A3 (en) | Foamable pharmaceutical compositions and methods for treating a disorder | |
MY138811A (en) | Preventive or therapeutic agent for glaucoma | |
AU2002352531A1 (en) | Use of at least one glycoinhibitor substance | |
NO20006604L (no) | Fremgangsmåter og transdermale sammensetninger for lindring av smerte | |
WO2002040056A8 (en) | Carrageenan viscoelastics for ocular surgery | |
DK1110554T3 (da) | Medicinal præparater til behandling af öjensygdomme | |
GB9317636D0 (en) | Use of dexmedetomidine | |
NZ506408A (en) | Pharmaceutical compositions | |
CA2253130A1 (en) | A medicament for treating obesity and improving lipid metabolism | |
WO1999043309A3 (en) | Anticonvulsant drugs and pharmaceutical compositions thereof | |
WO2002034201A3 (fr) | Utilisation d'inhibiteurs de l'apoptose des pericytes pour le traitement et/ou la prevention de la retinopathie diabetique | |
WO2000018387A3 (en) | Antibiotic compositions for treatment of the eye, ear and nose | |
EP0974363A4 (en) | REMEDIES FOR ADDICTION | |
WO2001010387A3 (en) | Antiviral therapy use of P-glycoprotein modulators | |
DE69935526D1 (de) | Supramolekulare komplexe enthaltende arzneimittel | |
WO2000010605A3 (en) | Preventives or remedies for eye circulatory failure | |
CA2118512A1 (en) | Agents for treating substance abuse disorders | |
SE8304616L (sv) | Retinaskyddsmedel for behandling av intraokulera blodningar, myopiska korioretinala dystrofier, medfodda retinadystrofier och retinabrennsar samt for forebyggande av skador vid laserkoagulering | |
MY122477A (en) | Sertraline oral concentrate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): CA JP KR US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): CA JP KR US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09762401 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999937066 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2341195 Country of ref document: CA Ref country code: CA Ref document number: 2341195 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020017002186 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 1999937066 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020017002186 Country of ref document: KR |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1020017002186 Country of ref document: KR |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999937066 Country of ref document: EP |